Verastem reported $-18090000 in Pre-Tax Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
AstraZeneca AZN:LN USD 3.09B 52M
Curis CRIS:US USD -13294000 2.65M
Cytokinetics CYTK:US USD -142310000 122.49M
Immunogen IMGN:US USD -77755000 15.73M
Laboratory Of America LH:US USD 551M 59.1M
Novartis NOVN:VX USD 4.06B 72M
Pfizer PFE:US USD 10.67B 3.11B
Tg Therapeutics TGTX:US USD -35818000 4.69M
Verastem VSTM:US USD -18090000 3.86M
YTE INCY:US USD 178.22M 131.36M